Kevin D. Moore serves as Executive at TransBiotec, Inc., where they oversee executive responsibilities. Since joining the company, Kevin D. Moore has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2019 involved receiving (via award) 800,000 shares valued at $0.
Kevin D. Moore currently holds 2,400,000 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin D. Moore has been a net neutral trader of IMLE stock. They have purchased $0 and sold $0 worth of shares.
Kevin D. Moore's most recent insider trade was on Dec 31, 2019, when they sold 800,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 31, 2019 | IMLE | $0 | Award | 800,000 | $N/A | Discretionary |